Teknova
Hollister
About Teknova
Teknova provides critical reagents for bioprocessing, bioproduction, and molecular diagnostics. We support customers in the research, clinical, and applied markets with standard catalog offerings and custom GMP products, including cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents. Focusing on agility and customer satisfaction, we strive to meet complex formulation and packaging requirements as well as provide fast turnaround for custom GMP products. As a partner to the biopharma sector, our R&D team offers expertise from prototype product design to guidance on GMP manufacturing of media, buffers, and reagents for the entire cell and gene therapy production workflow.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $38.3M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jul 2024)
- Ticker: nasdaq:TKNO
- Website: teknova.com
- Phone: 1-866-787-5563
Industries & Categories
Biotechnology, Chemical, Medical
Social Profiles
Canonical: https://fsome.com/organization/teknova-127600 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.